KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Clover Health Investments (CLOV) Preferred Shares (2020)

Clover Health Investments' Preferred Shares history spans 1 years, with the latest figure at $447.7 million for Q4 2020.

For Q4 2020, Preferred Shares changed N/A year-over-year to $447.7 million; the TTM value through Dec 2020 reached $447.7 million, changed N/A, while the annual FY2020 figure was $447.7 million, N/A changed from the prior year.
Preferred Shares reached $447.7 million in Q4 2020 per CLOV's latest filing.
In the past five years, Preferred Shares ranged from a high of $447.7 million in Q4 2020 to a low of $447.7 million in Q4 2020.